
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About


Relx PLC ADR (RELX)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: RELX (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit 22.16% | Avg. Invested days 56 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 93.03B USD | Price to earnings Ratio 37.62 | 1Y Target Price 53.23 |
Price to earnings Ratio 37.62 | 1Y Target Price 53.23 | ||
Volume (30-day avg) 628195 | Beta 0.48 | 52 Weeks Range 39.52 - 51.99 | Updated Date 04/1/2025 |
52 Weeks Range 39.52 - 51.99 | Updated Date 04/1/2025 | ||
Dividends yield (FY) 1.58% | Basic EPS (TTM) 1.34 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 20.5% | Operating Margin (TTM) 29.46% |
Management Effectiveness
Return on Assets (TTM) 11.72% | Return on Equity (TTM) 56% |
Valuation
Trailing PE 37.62 | Forward PE 29.07 | Enterprise Value 101156498892 | Price to Sales(TTM) 9.86 |
Enterprise Value 101156498892 | Price to Sales(TTM) 9.86 | ||
Enterprise Value to Revenue 8.26 | Enterprise Value to EBITDA 21.98 | Shares Outstanding 1845479936 | Shares Floating 1840092151 |
Shares Outstanding 1845479936 | Shares Floating 1840092151 | ||
Percent Insiders - | Percent Institutions 4.36 |
Analyst Ratings
Rating 4 | Target Price 50.12 | Buy - | Strong Buy 1 |
Buy - | Strong Buy 1 | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Relx PLC ADR

Company Overview
History and Background
Relx PLC ADR (RELX) was formed in 1993 through the merger of Reed Elsevier. Originating from publishing, it has transformed into a global provider of information and analytics for professional and business customers.
Core Business Areas
- Scientific, Technical & Medical: Provides information and analytics solutions to researchers and healthcare professionals. Includes journals, databases, and decision-support tools.
- Risk & Business Analytics: Offers data, analytics, and decision tools to assess and manage risk, detect fraud, and improve operational efficiency for businesses and governments.
- Legal: Delivers legal information and workflow solutions to legal professionals, including legal research platforms, case management software, and regulatory compliance tools.
- Exhibitions: Organizes trade shows and exhibitions across various industries, connecting buyers and sellers and facilitating business development.
Leadership and Structure
Relx PLC is led by CEO Paul Bascobert. The organizational structure includes a board of directors and executive management team responsible for overseeing the company's strategic direction and operational performance. It's a dual listed company in UK (REL) and NL (REN).
Top Products and Market Share
Key Offerings
- ScienceDirect: A leading platform for scientific research, providing access to millions of journal articles and book chapters. Market share estimated at 20% of academic journal market. Competitors: Wiley (WLY), Springer Nature.
- LexisNexis: A comprehensive legal research platform providing access to case law, statutes, and legal analysis. Estimated to have 30% market share in the legal information market. Competitors: Thomson Reuters (TRI).
- Accuity: Provides risk and compliance solutions, including KYC and anti-money laundering tools. Competitors: Dow Jones Risk & Compliance, Thomson Reuters World-Check.
- Embase: Biomedical literature database, competes with PubMed. Competitors: PubMed, Web of Science.
Market Dynamics
Industry Overview
The information and analytics industry is characterized by increasing digitization, demand for data-driven insights, and growing emphasis on risk management and regulatory compliance.
Positioning
Relx PLC ADR is a leading player in the information and analytics market, with a strong portfolio of established brands and a focus on innovation. Competitive advantages include proprietary data, advanced analytics capabilities, and a global presence.
Total Addressable Market (TAM)
The global information and analytics market is estimated at several hundred billion USD. Relx is well-positioned with significant market share.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Diverse product portfolio
- Global presence
- Recurring revenue model
- Advanced technology and analytics capabilities
Weaknesses
- High cost structure
- Exposure to economic cycles
- Dependence on key products and markets
- Vulnerability to cyber threats
Opportunities
- Expansion into emerging markets
- Development of new products and services
- Acquisition of complementary businesses
- Leveraging data analytics for new insights
Threats
- Increased competition
- Technological disruption
- Economic downturns
- Regulatory changes
- Piracy and copyright infringement
Competitors and Market Share
Key Competitors
- TRI
- WLY
- THLGY
Competitive Landscape
Relx PLC ADR faces competition from established players and emerging companies. It competes on the basis of product quality, innovation, and customer service.
Major Acquisitions
Emailage
- Year: 2020
- Acquisition Price (USD millions): 50
- Strategic Rationale: Enhanced fraud detection capabilities within LexisNexis Risk Solutions.
Growth Trajectory and Initiatives
Historical Growth: Relx PLC ADR has demonstrated consistent growth in revenue and earnings over the past years, driven by organic growth and acquisitions.
Future Projections: Analyst estimates suggest continued growth for Relx PLC ADR, driven by increasing demand for information and analytics solutions. No specific numbers provided.
Recent Initiatives: Recent initiatives include investing in new technologies, expanding into new markets, and acquiring complementary businesses.
Summary
Relx PLC ADR is a strong company with a diverse portfolio and global presence, benefiting from its established brands and recurring revenue model. However, it needs to watch out for technological disruption and increasing competition and maintain strong profit margins to succeed. They should maintain investing in new technologies and focusing on expanding into new markets to maintain market share. Overall, it is poised for continued growth.
Similar Companies

TRI

Thomson Reuters Corporation Common Shares



TRI

Thomson Reuters Corporation Common Shares
WLY

John Wiley & Sons


WLY

John Wiley & Sons
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst estimates
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Market share data are estimates and may vary. Financial figures should be verified from official company documents.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Relx PLC ADR
Exchange NYSE | Headquaters - | ||
IPO Launch date 1994-10-07 | CEO & Executive Director Mr. Erik Engstrom M.Sc Econ, M.Sc Eng., MBA | ||
Sector Industrials | Industry Specialty Business Services | Full time employees 34580 | Website https://www.relx.com |
Full time employees 34580 | Website https://www.relx.com |
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides scientific and medical information and data sets that help researchers and healthcare professionals to advance science and health outcomes. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.